NewsbenzingaBTIG Downgrades Foghorn Therapeutics to NeutralOct 2, 2026, 05:22 ET · PublishedSummaryOriginalView sourceArticle summaryPlease check the source for details.An excerpt from the original article.Related companiesFoghorn Therapeutics Inc. Common StockFHTXView stockLikeCommentsRepostShareComments —CommentLoading comments…
Comments —
Loading comments…